Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Controlled Attenuation Parameter (CAP) for the Assessment of Liver Steatosis in Liver Donors

NCT02798861 is registered in ClinicalTrials.gov with Andres Duarte-Rojo as lead sponsor.

NCT NCT02798861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02798861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Controlled Attenuation Parameter (CAP) for the Assessment of Liver Steatosis in Liver Donors
Lead sponsor
Andres Duarte-Rojo
Phase
Observational
Overall status
Completed
Start date
September 7, 2016
Completion date
June 1, 2019
Enrollment
160 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early allograft dysfunction, liver disease, liver steatosis, liver transplant, primary non-function